SPY308.08+2.53 0.83%
DIA257.85+2.58 1.01%
IXIC9,608.38+56.33 0.59%

Morgan Stanley Maintains Overweight on CVS Health, Raises Price Target of $77

Morgan Stanley maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $71 to $77.

Benzinga · 05/07/2020 11:48

Morgan Stanley maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $71 to $77.